1. Introduction {#sec1-molecules-22-02147}
===============

In the herbal markets and food industries of Korea and other East Asian countries, *Panax ginseng C.A. Meyer* is one of the most important herbal plants. Its roots have been used as a main constituent in oriental medicine \[[@B1-molecules-22-02147],[@B2-molecules-22-02147]\]. *P. ginseng* root contains many bioactive compounds including ginsenosides, peptides, polyacetylenic alcohols, fatty acids, and essential oils \[[@B3-molecules-22-02147]\]. Among these compounds, ginsenosides are considered critical ingredients, having various pharmacological effects, such as enhancing the immune system, and anti-tumor and anti-diabetes activities \[[@B4-molecules-22-02147],[@B5-molecules-22-02147],[@B6-molecules-22-02147],[@B7-molecules-22-02147]\]. Each ginsenoside has specific activities, and the efficacy of ginseng is determined by the ginsenoside contents. Due to its biological utility, the production and use of ginsenosides has been receiving increased attention. More than 150 ginsenosides have been isolated and identified from the *P. ginseng* plant \[[@B8-molecules-22-02147],[@B9-molecules-22-02147]\]. In particular, its distinct parts including the roots, leaves, stems, and berries are considered as good sources of ginsenosides \[[@B10-molecules-22-02147],[@B11-molecules-22-02147],[@B12-molecules-22-02147]\]. The qualitative and quantitative ginsenoside contents may differ depending on the plant part of *P. ginseng* \[[@B13-molecules-22-02147],[@B14-molecules-22-02147]\]. Hence, to evaluate the efficacy of different ginseng parts and their effective production of ginsenosides, profiling the various ginsenosides from the distinct parts of *P. ginseng* is required.

To assess the levels of various ginsenosides from a complex *P. ginseng* extract, a sensitive and reliable analytical method is necessary. To analyze ginsenosides, high performance liquid chromatography (HPLC) coupled with a UV detector \[[@B15-molecules-22-02147],[@B16-molecules-22-02147]\], or an evaporative light scattering detector (ELSD) \[[@B17-molecules-22-02147],[@B18-molecules-22-02147]\] are typically used. However, due to the limited availability of standard samples, only a few ginsenosides have been quantified. Liquid chromatography (LC) coupled with electrospray ionization/mass spectrometry (ESI/MS) has emerged as a robust tool for the comprehensive profiling of various ginsenosides \[[@B19-molecules-22-02147],[@B20-molecules-22-02147],[@B21-molecules-22-02147]\]. Within MS, a full mass scan based on quadrupole time of flight (QTOF)/MS is a sensitive detector used to measure the exact mass values of target and non-target compounds \[[@B22-molecules-22-02147],[@B23-molecules-22-02147]\]. The ultra-performance LC (UPLC) system provides high resolution separation using a small particle size column, and is effective for analyzing various compounds in a complex mixture \[[@B24-molecules-22-02147]\].

In this study, UPLC-QTOF/MS with an in-house library was used to perform a comprehensive profiling of ginsenosides from the roots, leave, stems, and berries of *P. ginseng*. To construct an in-house library and the quantification of ginsenosides, we used a total of 58 standard samples, including malonyl-ginsenosides (MGRs), isolated in our laboratory. The qualitative and quantitative contents of ginsenosides were characterized in the distinct parts of *P. ginseng*.

2. Materials and Methods {#sec2-molecules-22-02147}
========================

2.1. Standard Constituents and Reagents {#sec2dot1-molecules-22-02147}
---------------------------------------

HPLC-grade methanol (MeOH), water, and ACN were obtained from Fisher Scientific Korea (Seoul, Korea). HPLC-grade formic acid was purchased from Fluka Analytical, Sigma Aldrich Chemie GmbH (Steinheim, Germany). The ginsenoside standards used in this study were isolated and purified from *P. ginseng* roots and red ginseng by a series of chromatography procedures in our laboratory, and the information for 30 ginsenosides was reported in our previous study \[[@B25-molecules-22-02147]\]. The structures of other ginsenosides were determined based on the spectroscopic data (MS, hydrogen nuclear magnetic resonance (^1^H-NMR), and carbon-13 (^13^C)-NMR) in the previous literatures: fKa \[[@B26-molecules-22-02147]\], nR4 \[[@B27-molecules-22-02147]\], nR2-R \[[@B28-molecules-22-02147]\], Rh1-R \[[@B29-molecules-22-02147]\], Ra3 \[[@B26-molecules-22-02147]\], M-Rb1 \[[@B30-molecules-22-02147]\], M-Rc \[[@B31-molecules-22-02147]\], M-Rb2 \[[@B30-molecules-22-02147]\], M-Rd \[[@B31-molecules-22-02147]\], CO \[[@B32-molecules-22-02147]\], GyL \[[@B33-molecules-22-02147]\], GyLI \[[@B33-molecules-22-02147]\], nFt1 \[[@B34-molecules-22-02147]\], Rg3-R \[[@B29-molecules-22-02147]\], Mc \[[@B35-molecules-22-02147]\], and CY \[[@B35-molecules-22-02147]\]. Rf, Rk1, Ro, Rg2-R, PPD, and PPT were purchased from Sigma Aldrich (St. Louis, MO, USA). Rk3, Rh4, GyXVII, and XLIX were purchased from Chemfaces (Wuhan, China). Rk2 and GyA were purchased from ALB technology (Mongkok Kowloon, Hong Kong, China).

2.2. Panax ginseng Samples {#sec2dot2-molecules-22-02147}
--------------------------

*Panax ginseng* was cultivated in the experimental field of the National Institute of Horticultural and Herbal Science, Rural Development Administration (RDA) at Chungbuk, Eumseong, Korea (36° N, 127° E), according to the "ginseng GAP standard cultivation guide" protocol developed by RDA, Republic of Korea \[[@B36-molecules-22-02147]\]. A voucher specimen (NIHHS-14S01) was deposited at the Herbarium of the Department of Herbal Crop Research, National Institute of Horticultural and Herbal Science, Rural Development Administration, Eumseong, Republic of Korea. Six years into its growing season, in the month of July, the roots, stems and leaves, and berries were harvested, and stored in a deep freezer at −80 °C until further processing.

2.3. Extraction of Ginsenosides {#sec2dot3-molecules-22-02147}
-------------------------------

The samples of ginseng roots, stems and leaves, and berries were dried at 40 °C in a forced-air, convection-drying oven for 48 h after washing, and then weighed. For the ginseng root, the main roots were used for experiments after removing the lateral and fine roots. Each sample was ground (\<0.5 mm) using a mixer (Hanil, Seoul, Korea) and thoroughly mixed, and subsamples were homogenized further using a Retsch MM400 mixer mill (Retsch GmbH, Haan, Germany) for analyses. Fine powder was weighed (200 mg), suspended in 2 mL of 70% (*v*/*v*) methanol, and ultrasonically extracted for 30 min at 50 °C. Each sample was centrifuged at 13,500 rpm for 5 min. The solution was filtered through a syringe filter (0.22 µm) and injected directly into the UPLC system.

2.4. UPLC-QTOF/MS Conditions for Ginsenoside Profiling {#sec2dot4-molecules-22-02147}
------------------------------------------------------

UPLC was performed using a Waters ACQUITY H-Class UPLC (Waters Corp., Milford, MA, USA) with an ACQUITY BEH C18 column (2.1 mm × 100 mm; 1.7 µm). The column oven was maintained at 40 °C, and the mobile phases included solvent A \[water and 0.1% formic acid (*v*/*v*)\] and solvent B \[acetonitrile and 0.1% formic acid (*v*/*v*)\]. The elution gradient was as follows: 0--0.5 min, B 15%; 0.5--1 min, B 15--20%; 1--6 min, B 20%; 6--13 min, B 20--30%; 13--23 min, B 30--35%; 23--24 min, B 35--38%; 24--27 min, B 38--60%; 27--31 min, B 60--90%; 31--32 min, B 90--15%; and 32--35 min, B 15%. The flow rate was 450 μL/min, and the injection volume was 2 μL for each run.

Next, MS analysis was performed using a Waters Xevo G2-S QTOF MS (Waters Corp., Milford, MA, USA) operating in negative ion mode. The mass spectrometers performed alternating high- and low-energy scans, known as the MS^E^ acquisition mode. The operating parameters were set as follows: cone voltage 40 V; capillary 3.0 kV; source temperature 120 °C; desolvation temperature 550 °C; cone gas flow 30 L/h; and desolvation gas flow at 800 L/h. Accurate mass measurements were obtained by means of an automated calibration delivery system that contained an internal reference \[Leucine-enkephalin, *m*/*z* 554.262 (ESI-)\]. Data were collected between 100 and 2000 *m*/*z*.

2.5. Data Processing and Multivariate Analysis {#sec2dot5-molecules-22-02147}
----------------------------------------------

All MS^E^ data were collected and processed using UNIFI 1.8 (Waters Corp., Milford, MA, USA). Data within UNIFI 1.8 were passed through the apex peak detection and alignment processing algorithms. The intensity of each ion was normalized with respect to the total ion count to generate a data matrix having RT, *m*/*z* value, and the normalized peak area. Charged species, salt adducts, and fragments were all automatically aligned and grouped. The three-dimensional data, including peak number (RT-*m*/*z* pair), sample name, and normalized peak areas, were exported to the EZinfo software 3.0.3 (UMETRICS) for PCA. The processed data were also entered into the MetaboAnalyst website (<http://www.metaboanalyst.ca>) to perform HCA.

3. Results and Discussion {#sec3-molecules-22-02147}
=========================

3.1. UPLC-QTOF/MS with an In-House Library to Profile Various Ginsenosides {#sec3dot1-molecules-22-02147}
--------------------------------------------------------------------------

The sensitivity of MS-based analytical methods has increased to enable the detection of compounds with limited abundance in biological samples. Thus, LC-MS methods have been widely used to analyze major compounds in various herbal medicines. For the detailed characterization of *P. ginseng*, assessing the levels of both the high- and low-abundance ginsenosides is important. In our previous study \[[@B25-molecules-22-02147]\], UPLC-QTOF/MS was used to analyze 30 ginsenosides. The optimal UPLC method was effective for separating various ginsenosides. In the identification of ginsenosides, QTOF/MS was also sensitive and reliable for measuring the exact mass values of the compounds. In this study, the LC-MS method was simultaneously applied to profile 58 ginsenosides. [Figure S1](#app1-molecules-22-02147){ref-type="app"} represented the molecular structures of these ginsenosides. First, these ginsenoside standards were purchased or obtained from the experiments by isolating and purifying them from *P. ginseng*. In our laboratory, we collected four MGRs that contained a malonyl residue, M-Rb1, M-Rb2, M-Rc, and M-Rd, which is linked to the glucose in the compounds. Isolating and purifying the MGRs from the extracted mixture of *P. ginseng* is difficult in practice. Due to their instability when exposed to heat, care must be taken when handling and preserving MGR compounds.

Next, for the comprehensive profiling of various ginsenosides, 58 ginsenoside standards were used to optimize the UPLC-QTOF/MS conditions. By using the UPLC system with an ACQUITY BEH C18 column, these standards were well separated after 30 min at a flow rate of 450 µL/min. The base peak intensity (BPI) chromatograms of the 58 ginsenosides are shown in [Figure 1](#molecules-22-02147-f001){ref-type="fig"}. Among these ginsenosides, 16 isomeric well-separated pairs were found: C~36~H~60~O~7~ (Rk2 or Rh3), C~36~H~60~O~8~ (Rk3, Rh4, fKa, or Rh6), C~36~H~62~O~8~ (Rh2 or CK), C~36~H~62~O~9~ (Rh1, Rh1-R, or F1), C~41~H~70~O~12~ (Mc or CY), C~41~H~70~O~13~ (nR2, F5, nR2-R, or F3), C~42~H~70~O~12~ (Rg4, F4, Rk1, or Rg5), C~42~H~72~O~13~ (Rg2, Rg2-R, F2, Rg3, or Rg3-R), C~42~H~72~O~14~ (Rg1, pF11, Rf, GyL, or GyLI), C~47~H~80~O~17~ (nFe, CO, or nFt1), C~48~H~82~O~18~ (Re, Rd, or GyXVII), C~48~H~82~O~19~ (gRf or vR4), C~53~H~90~O~22~ (Rc, Rb2, or Rb3), C~56~H~92~O~25~ (M-Rc or M-Rb2), C~58~H~98~O~26~ (Ra1 or Ra2), and C~59~H~100~O~27~ (nR4 or Ra3). Although several peaks overlapped with each other, identifying each peak was possible, based on its exact mass values obtained by QTOF/MS. In the negative ion mode, ginsenosides were detected as \[M + COOH\]^−^ ions and \[M − H\]^−^ ions with high mass accuracy (\<2.5 ppm). For the exact identification of ginsenosides, we constructed an in-house library using the UNIFI software. Information about the compound's name, molecular formula, retention time (RT), mass accuracy, and adduct was listed in the library for the 58 ginsenosides ([Table 1](#molecules-22-02147-t001){ref-type="table"}). Next, a validation study was performed to prove the performance of the UPLC-QTOF/MS method for profiling the ginsenosides. For this, the standard curves of the 58 ginsenosides were constructed, and their linearity range and correlation (*R*^2^) were calculated. The limits of detection (LODs) of each standard are provided in [Table S1](#app1-molecules-22-02147){ref-type="app"}. The *R*^2^ of each ginsenoside analysis was, at minimum, above 0.9908, proving the high reliability of the quantitative analysis of the ginsenosides. LODs also showed the high sensitivity of this method for detecting ginsenosides. For example, in the case of Ra3, Ro, M-Rb2, Rd, GyL, GyLI, Rg3, Mc, and Cy, the two picogram (pg) of these compounds was detected by UPLC-QTOF/MS.

3.2. Profiling of Various Ginsenosides from the Roots, Stems, Leaves, and Berries of Panax ginseng {#sec3dot2-molecules-22-02147}
--------------------------------------------------------------------------------------------------

In this study, the constructed UPLC-QTOF/MS with an in-house library was applied to profile various ginsenosides from the roots, stems, leaves, and berries of *P. ginseng*. The numbers of individual samples were as follows: ginseng root (GR) (*n* = 10), stem and leaf (GS) (*n* = 10), and berry (GB) (*n* = 10). To extract various ginsenosides from individual samples, 70% (*v*/*v*) methanol was used. The extracts were analyzed using UPLC-QTOF/MS; each piece of data was then processed using the UNIFI software. [Figure 2](#molecules-22-02147-f002){ref-type="fig"} shows the representative BPI chromatograms of ginsenoside extracts from GR, GS, and GB. UPLC was able to separate the ginsenosides and other metabolites in 30 min. The intensities of several peaks were different dependent on the sample. For example, overall, the GR sample had lower intensity peaks compared to the other samples. The GS sample had higher intensity peaks than the GB sample, eluted for 5--10 min and 18--26 min. However, the GB sample had higher intensity peaks than the GS sample, eluted for 5--10 min. These demonstrated that GR, GS, and GB have distinct metabolite compositions, including ginsenosides.

First, all the processed data were exported to the EZinfo software for principal component analysis (PCA). PCA helps visualize the general clustering trends among individual samples, and the scatter of the points indicates the similarities or differences between the metabolite data of the samples. In the score plot, the GR, GS, and GB were well-differentiated ([Figure 3](#molecules-22-02147-f003){ref-type="fig"}A). Moreover, in the loading plot, we identified the main variables that differentiate the three groups in the score plot. Each point represented the *m*/*z*-RT pairs of molecules. Based on the in-house library, the nine variables of the loading plot were identified as several ginsenosides ([Figure 3](#molecules-22-02147-f003){ref-type="fig"}B). Next, in the data processing, a total of 39 ginsenosides were identified from the three samples. Using the in-house library, the numbers of identified ginsenosides from three samples were as follows: 27 in GR, 32 in GS, and 29 in GB. The ginsenosides datasets were then subjected to hierarchical clustering analysis (HCA). As a result, the three groups were clearly differentiated. The different levels of the 39 ginsenosides in the ginseng roots, stems and leave, and berries are described in the heatmap in [Figure 4](#molecules-22-02147-f004){ref-type="fig"}. This demonstrated the major ginsenosides that were found in each ginseng part.

3.3. Quantification of Ginsenosides from the Roots, Stems and Leaves, and Berries of Panax ginseng {#sec3dot3-molecules-22-02147}
--------------------------------------------------------------------------------------------------

Next, we quantified the 39 ginsenosides in the individual samples. The standard curve of each ginsenoside was applied to determine its actual amount in the ginseng samples. The quantification was based on 10 biological replicate analysis of each ginseng sample (*n* = 10), and the amounts are described as mean ± SD in [Table 2](#molecules-22-02147-t002){ref-type="table"}. This displays the qualitative and quantitative ginsenoside contents in the different *P. ginseng* parts. Previously, Wang et al. has reported the HPLC-UV--based quantification of 12 ginsenosides from ginseng root, rootlet, leaf, and berry \[[@B14-molecules-22-02147]\]. From the five parts such as root, root-hair, rhizome, stem, and leaf, Shi et al. quantified seven ginsenosides by HPLC-UV \[[@B13-molecules-22-02147]\], and Qu et al. quantified 12 ginsenosides by HPLC-ELSD \[[@B36-molecules-22-02147]\]. Compared to these reports, this study detail characterized a total of 39 ginsenosides with high- or low-abundance from ginseng root, stem and leaf, and berry. As our results, ginsenosides, such as nR4, Ra2, Ra3, and Ra1, were uniquely found in GR. Furthermore, GS uniquely contained Rb3, Mc, CY, Rh2, and Rh1-R. F1 and Rg4 were only detected in GB. Although most of unique ginsenosides are low-abundant, their profiles are valuable to characterize the ginsenoside contents of each ginseng part. In the quantification, GR had highest amounts of Rf, Rb1, and Ro, compared to the other samples. GS had highest amounts of Rg1, vR4, F5, Rh1, F3, Rc, Rb2, Rd, CO, F2, Rg3, CK, and Rk1. GB had highest amounts of gRf, nR1, Re, nR2, Rg2, Rg2-R, M-Rb1, M-Rc, M-Rb2, M-Rd, F4, and Rg5. Previously, two papers have reported that GR had the highest amounts of Rb1, GB had the highest amounts of Rg2, and GS had the highest amounts of Rg1, Rh1, Rd, and Rg3 \[[@B14-molecules-22-02147],[@B36-molecules-22-02147]\]. Interestingly, these results have been matched to ours. Rb3 and Rh1-R are also equally analyzed from GS \[[@B13-molecules-22-02147],[@B14-molecules-22-02147]\]. On the other hand, Wang et al. has reported that Re and Rc are mainly consisted in GS and GR, respectively \[[@B14-molecules-22-02147]\]. As our results, GB had highest amounts of Re, and this is matched to another previous paper \[[@B37-molecules-22-02147]\]. The quantification of several ginsenosides can differ depending on ginseng's cultivars and growing conditions.

Each ginsenoside has specific activities, and the efficacies of GR, GS, and GB are determined by the ginsenoside contents. Here, we focused on the pharmacological activities of ginsenosides which are mainly or uniquely consisted in each ginseng part. By searching previous literatures \[[@B5-molecules-22-02147],[@B6-molecules-22-02147],[@B15-molecules-22-02147],[@B38-molecules-22-02147],[@B39-molecules-22-02147],[@B40-molecules-22-02147],[@B41-molecules-22-02147],[@B42-molecules-22-02147],[@B43-molecules-22-02147],[@B44-molecules-22-02147],[@B45-molecules-22-02147],[@B46-molecules-22-02147]\], we found six kinds of activities in 17 ginsenosides ([Table S2](#app1-molecules-22-02147){ref-type="app"}). In summary, three ginsenosides (Rf, Rb1, Ro) consisted in GR shows anti-inflammation effect and lymphocyte proliferative capacity. Moreover, 10 ginsenosides (Rg1, Rc, Rb2, Rd, F2, Rg3, CK, Rb3, Rh2, Rh1-R) consisted in GS shows six activities (anti-cancer, anti-diabetes, anti-inflammation, lymphocyte proliferative capacity, immunomodulating activity, chemopreventive effect). Lastly, four ginsenosides (Re, Rg2, Rg2-R, F1) consisted in GB shows four activities (anti-cancer, anti-diabetes, anti-inflammation, lymphocyte proliferative capacity). These results demonstrated that not only GR, but also GS and GB are good sources to obtain ginsenosides having pharmacological activities. By detail profiling of various ginsenosides, it was possible to find the efficacies of ginseng root, stems, leaves, and berries.

4. Conclusions {#sec4-molecules-22-02147}
==============

In conclusion, this study optimized an analytical method based on UPLC-QTOF/MS with an in-house library to profile 58 ginsenosides. Furthermore, using this method, we determined the quantitative contents of 39 ginsenosides from GR, GS, and GB. These results demonstrated that not only the ginseng root, but also the stems, leaves, and berries are good sources of ginsenosides. Each ginsenoside has specific activities. Thus, in the basis of ginsenosides profiling and quantification, we can assess the pharmacological utility of different ginseng parts. Moreover, ginsenoside contents may differ depending on ginseng's cultivars, growing years, growing regions, etc. Finally, the proposed UPLC-QTOF/MS method for ginsenoside profiling is a good tool for evaluating various ginseng samples as sources for ginsenosides.
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Supplementary materials are available online. Figure S1. Molecular structures of 58 ginsenosides listed in [Table 1](#molecules-22-02147-t001){ref-type="table"}. Table S1. Validation study for the analysis of the 58 ginsenosides using UPLC-QTOF/MS. Table S1. Pharmacological activities of 17 ginsenosides which are mainly or uniquely consisted in ginseng root (GR), stem and leaf (GS), and berry (GB).
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![Base peak intensity (BPI) chromatogram of 58 ginsenoside standards. The peaks of (**1**)--(**58**) are aligned with the 58 ginsenosides listed in [Table 1](#molecules-22-02147-t001){ref-type="table"}.](molecules-22-02147-g001){#molecules-22-02147-f001}

![BPI chromatogram of ginsenoside extracts from three samples of (**A**) ginseng roots (GR), (**B**) stems and leaves (GS), and (**C**) berries (GB).](molecules-22-02147-g002){#molecules-22-02147-f002}

![(**A**) Principal component analysis (PCA) score plot and (**B**) loading plot of ginsenoside extracts from ginseng roots (GR) (*n* = 10), stems and leaves (GS) (*n* = 10), and berries (GB) (*n* = 10). In the PCA loading plot, each point was identified as follows: ginsenoside (a) Ro (b) Rb1, (c) M-Rb1, (d) M-Rc, (e) M-Rb2, (f) M-Rd, (g) Re, (h) F3, (i) unknown, and (j) Rd.](molecules-22-02147-g003){#molecules-22-02147-f003}

![Hierarchical clustering analysis of the 39 ginsenoside datasets from the ginseng root (GR) (*n* = 10), stems and leaves (GS) (*n* = 10), and berries (GB) (*n* =10).](molecules-22-02147-g004){#molecules-22-02147-f004}

molecules-22-02147-t001_Table 1

###### 

In-house library for the analysis of 58 ginsenosides using ultra-performance liquid chromatography-quadrupole time of flight mass spectrometry (UPLC-QTOF/MS).

  No.      RT (min)   Ginsenosides                       Molecular Formula   Expected Neutral Mass (Da)   Observed Neutral Mass (Da)   QTOF/MS (ESI-) (*m*/*z*)   Mass Accuracy (ppm)   Adducts
  -------- ---------- ---------------------------------- ------------------- ---------------------------- ---------------------------- -------------------------- --------------------- ---------
  **1**    3.58       20-O-Glucoginsenoside Rf (gRf)     C~48~H~82~O~19~     962.545                      962.5453                     1007.5435                  0.26                  +HCOO
  **2**    4.07       Notoginsenoside R1 (nR1)           C~47~H~80~O~18~     932.5345                     932.5343                     977.5325                   0.2                   +HCOO
  **3**    5.36       Ginsenoisde Rg1 (Rg1)              C~42~H~72~O~14~     800.4922                     800.4908                     845.489                    1.62                  +HCOO
  **4**    5.66       Ginsenoside Re (Re)                C~48~H~82~O~18~     946.5501                     946.5503                     991.5485                   0.16                  +HCOO
  **5**    8.05       Floralginsenoside Ka (fKa)         C~36~H~62~O~11~     670.4292                     670.4295                     715.4277                   0.34                  +HCOO
  **6**    8.46       Ginsenoside Rh6 (Rh6)              C~36~H~62~O~11~     670.4292                     670.4291                     715.4273                   0.19                  +HCOO
  **7**    10.72      Ginsenoside Rh23 (Rh23)            C~37~H~64~O~10~     668.4499                     668.4507                     713.4489                   1.06                  +HCOO
  **8**    11.2       Vinaginsenoside R4 (vR4)           C~48~H~82~O~19~     962.545                      962.5452                     1007.5434                  0.19                  +HCOO
  **9**    11.94      Pseudo-ginsenoside F11 (pF11)      C~42~H~72~O~14~     800.4922                     800.4932                     845.4914                   1.22                  +HCOO
  **10**   12.11      Ginsenoside Rf (Rf)                C~42~H~72~O~14~     800.4922                     800.4922                     845.4904                   0.01                  +HCOO
  **11**   12.81      Notoginsenoside R2 (nR2)           C~41~H~70~O~13~     770.4816                     770.4823                     815.4805                   0.83                  +HCOO
  **12**   13.15      Notoginsenoside R4 (nR4)           C~59~H~100~O~27~    1240.6452                    1240.6455                    1285.6437                  0.2                   +HCOO
  **13**   13.43      Ginsenoside F5 (F5)                C~41~H~70~O~13~     770.4816                     770.4819                     815.4801                   0.33                  +HCOO
  **14**   13.56      Ginsenoside Rh1 (Rh1)              C~36~H~62~O~9~      638.4394                     638.4392                     683.4374                   0.31                  +HCOO
  **15**   13.58      20(R)-Notoginsenoside R2 (nR2-R)   C~41~H~70~O~13~     770.4816                     770.4815                     815.4797                   0.18                  +HCOO
  **16**   13.7       Ginsenoside Rg2 (Rg2)              C~42~H~72~O~13~     784.4973                     784.4984                     829.4966                   1.38                  +HCOO
  **17**   13.9       Ginsenoside F3 (F3)                C~41~H~70~O~13~     770.4816                     770.4811                     815.4793                   0.63                  +HCOO
  **18**   14.03      20(R)-Ginsenoside Rg2 (Rg2-R)      C~42~H~72~O~13~     784.4973                     784.496                      829.4942                   1.58                  +HCOO
  **19**   14.03      20(R)-Ginsenoside Rh1 (Rh1-R)      C~36~H~62~O~9~      638.4394                     638.4397                     683.4379                   0.47                  +HCOO
  **20**   14.35      Ginsenoside Ra2 (Ra2)              C~58~H~98~O~26~     1210.6346                    1210.6346                    1255.6328                  0.01                  +HCOO
  **21**   14.51      Ginsenoside Ra3 (Ra3)              C~59~H~100~O~27~    1240.6452                    1240.6447                    1285.6429                  0.36                  +HCOO
  **22**   14.53      Ginsenoside Rb1 (Rb1)              C~54~H~92~O~23~     1108.6029                    1108.6006                    1153.5988                  2.02                  +HCOO
  **23**   14.58      Gypenoside XLIX (XLIX)             C~52~H~86~O~21~     1046.5662                    1046.5658                    1091.564                   0.31                  +HCOO
  **24**   15.04      Malonyl ginsenoside Rb1 (M-Rb1)    C~57~H~94~O~26~     1194.6033                    1194.6057                    1193.5984                  2                     --H
  **25**   15.25      Ginsenoside Rc (Rc)                C~53~H~90~O~22~     1078.5924                    1078.5925                    1123.5907                  0.1                   +HCOO
  **26**   15.47      Ginsenoside Ra1 (Ra1)              C~58~H~98~O~26~     1210.6346                    1210.633                     1255.6312                  1.27                  +HCOO
  **27**   15.69      Ginsenoside Ro (Ro)                C~48~H~76~O~19~     956.4981                     956.4978                     955.4905                   0.28                  --H
  **28**   15.8       Ginsenoside F1 (F1)                C~36~H~62~O~9~      638.4394                     638.4395                     683.4377                   0.11                  +HCOO
  **29**   15.9       Malonyl ginsenoside Rc (M-Rc)      C~56~H~92~O~25~     1164.5928                    1164.5947                    1163.5874                  1.6                   --H
  **30**   16.25      Ginsenoside Rb2 (Rb2)              C~53~H~90~O~22~     1078.5924                    1078.5913                    1123.5895                  0.99                  +HCOO
  **31**   16.6       Ginsenoside Rb3 (Rb3)              C~53~H~90~O~22~     1078.5924                    1078.5915                    1123.5897                  0.81                  +HCOO
  **32**   16.9       Malonyl ginsenoside Rb2 (M-Rb2)    C~56~H~92~O~25~     1164.5928                    1164.5923                    1163.585                   0.4                   --H
  **33**   18.28      Gypenoside A (GyA)                 C~46~H~74~O~17~     898.4926                     898.4915                     943.4897                   1.21                  +HCOO
  **34**   18.29      Ginsenoside Rd (Rd)                C~48~H~82~O~18~     946.5501                     946.5495                     991.5477                   0.59                  +HCOO
  **35**   18.97      Malonyl ginsenoside Rd (M-Rd)      C~51~H~84~O~21~     1032.5505                    1032.5498                    1031.5425                  0.7                   --H
  **36**   20.4       Gypenoside XVII (GyXVII)           C~48~H~82~O~18~     946.5501                     946.5497                     991.5479                   0.47                  +HCOO
  **37**   21.96      Notoginsenoisde Fe (nFe)           C~47~H~80~O~17~     916.5396                     916.5393                     961.5375                   0.22                  +HCOO
  **38**   23.29      Compound O (CO)                    C~47~H~80~O~17~     916.5396                     916.5396                     961.5378                   0.1                   +HCOO
  **39**   23.46      Ginsenoside Rg4 (Rg4)              C~42~H~70~O~12~     766.4867                     766.4875                     811.4857                   0.91                  +HCOO
  **40**   23.84      Ginsenoside Rk3 (Rk3)              C~36~H~60~O~8~      620.4288                     620.4292                     665.4274                   0.51                  +HCOO
  **41**   24.28      Ginsenoside F4 (F4)                C~42~H~70~O~12~     766.4867                     766.4865                     811.4847                   0.27                  +HCOO
  **42**   24.68      Ginsenoside Rh4 (Rh4)              C~36~H~60~O~8~      620.4288                     620.4275                     665.4257                   2.01                  +HCOO
  **43**   25.15      Gypenoside L (GyL)                 C~42~H~72~O~14~     800.4922                     800.4905                     845.4887                   2.1                   +HCOO
  **44**   25.19      Ginsenoside F2 (F2)                C~42~H~72~O~13~     784.4973                     784.4968                     829.495                    0.6                   +HCOO
  **45**   25.34      Gypenoside LI (GyLI)               C~42~H~72~O~14~     800.4922                     800.4909                     845.4891                   1.6                   +HCOO
  **46**   25.57      Notoginsenoside Ft1 (nFt1)         C~47~H~80~O~17~     916.5396                     916.5417                     961.5399                   2.26                  +HCOO
  **47**   25.78      Protopanaxatiol (PPT)              C~30~H~52~O~4~      476.3866                     476.3862                     521.3844                   0.71                  +HCOO
  **48**   26.01      20(S)-Ginsenoside Rg3 (Rg3)        C~42~H~72~O~13~     784.4973                     784.498                      829.4962                   0.9                   +HCOO
  **49**   26.2       20(R)-Ginsenoside Rg3 (Rg3-R)      C~42~H~72~O~13~     784.4973                     784.4989                     829.4971                   1.97                  +HCOO
  **50**   26.37      Ginsenoisde Mc (Mc)                C~41~H~70~O~12~     754.4867                     754.4867                     799.4849                   0                     +HCOO
  **51**   26.52      Compound Y (CY)                    C~41~H~70~O~12~     754.4867                     754.4849                     799.4831                   2.3                   +HCOO
  **52**   27.35      Compound K (CK)                    C~36~H~62~O~8~      622.4445                     622.4433                     667.4415                   1.8                   +HCOO
  **53**   27.43      Ginsenoside Rk1 (Rk1)              C~42~H~70~O~12~     766.4867                     766.4861                     811.4843                   0.81                  +HCOO
  **54**   27.55      Ginsenoside Rg5 (Rg5)              C~42~H~70~O~12~     766.4867                     766.4873                     811.4855                   0.73                  +HCOO
  **55**   27.7       Ginsenoside Rh2 (Rh2)              C~36~H~62~O~8~      622.4445                     622.4441                     667.4423                   0.52                  +HCOO
  **56**   29.04      Ginsenoside Rk2 (Rk2)              C~36~H~60~O~7~      604.4339                     604.4341                     649.4323                   0.35                  +HCOO
  **57**   29.15      Ginsenoside Rh3 (Rh3)              C~36~H~60~O~7~      604.4339                     604.434                      649.4322                   0.17                  +HCOO
  **58**   30.04      Protopanaxadiol (PPD)              C~30~H~52~O~3~      460.3916                     460.3917                     505.3899                   0.19                  +HCOO
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###### 

Quantification of 39 ginsenosides from the roots, stems and leaves, and berries of *P. ginseng*. Values are expressed as mg/g.

  No.   Ginsenosides   Roots           Stems and Leaves   Berries         No.   Ginsenosides   Root              Stems and Leaves   Berry
  ----- -------------- --------------- ------------------ --------------- ----- -------------- ----------------- ------------------ ---------------
  1     gRf            1.8 ± 0.1       0.3 ± 0.1          3.6 ± 1.1       21    Ro             0.15 ± 0.01       0.014 ± 0.002      0.014 ± 0.002
  2     nR1            0.06 ± 0.01     0.03 ± 0.01        1.2 ± 0.2       22    M-Rc           0.9 ± 0.1         1.08 ± 0.04        4.7 ± 0.5
  3     Rg1            3.1 ± 0.2       9.6 ± 0.5          8.9 ± 4.3       23    Rb2            0.6 ± 0.1         2.8 ± 0.1          2.3 ± 0.6
  4     Re             3.0 ± 0.3       17 ± 1             26 ± 8          24    Rb3            not detected      0.5 ± 0.1          not detected
  5     vR4            0.007 ± 0.001   1.2 ± 0.1          0.9 ± 0.1       25    M-Rb2          0.9 ± 0.1         1.6 ± 0.1          6.8 ± 0.5
  6     Rf             4.6 ± 0.2       0.30 ± 0.01        3.4 ± 1.1       26    Rd             0.15 ± 0.01       7.1 ± 0.2          2.3 ± 0.5
  7     nR2            1.1 ± 0.1       0.7 ± 0.1          4.5 ± 1.3       27    M-Rd           0.014 ± 0.001     3.1 ± 0.1          5.3 ± 0.4
  8     nR4            0.14 ± 0.02     not detected       not detected    28    CO             0.06 ± 0.01       12.6 ± 0.1         0.4 ± 0.1
  9     F5             not detected    5.8 ± 0.2          2.8 ± 0.3       29    Rg4            not detected      not detected       0.06 ± 0.03
  10    Rh1            0.021 ± 0.002   0.24 ± 0.01        0.04 ± 0.02     30    F4             not detected      0.4 ± 0.1          2.1 ± 0.8
  11    Rg2            0.17 ± 0.01     0.61 ± 0.03        0.6 ± 0.5       31    F2             0.0019 ± 0.0006   2.7 ± 0.3          0.03 ± 0.01
  12    F3             not detected    5.3 ± 0.2          4.1 ± 0.4       32    Rg3            0.0004 ± 0.0002   0.09 ± 0.01        0.007 ± 0.001
  13    Rg2-R          not detected    0.008 ± 0.001      0.06 ± 0.03     33    Mc             not detected      0.24 ± 0.04        not detected
  14    F1             not detected    not detected       0.005 ± 0.001   34    CY             not detected      0.08 ± 0.02        not detected
  15    Ra2            3.2 ± 0.1       not detected       not detected    35    CK             0.0010±0.0004     0.003±0.001        0.002 ± 0.001
  16    Ra3            0.9 ± 0.1       not detected       not detected    36    Rk1            not detected      1.18±0.02          1.153 ± 0.004
  17    Rb1            3.8 ± 0.3       0.08 ± 0.01        2.8 ± 0.6       37    Rg5            0.031 ± 0.004     not detected       0.08 ± 0.01
  18    M-Rb1          4.7 ± 0.5       0.7 ± 0.1          9.9 ± 1.2       38    Rh2            not detected      0.011 ± 0.002      not detected
  19    Rc             0.9 ± 0.1       3.5 ± 0.1          not detected    39    Rh1-R          not detected      0.0028 ± 0.0004    not detected
  20    Ra1            0.6 ± 0.2       not detected       not detected                                                              
